Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma. (Q53655318)

16 May 2018

title

Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma. (English)

1 reference

16 May 2018

5

Randy D Gascoyne

1 reference

16 May 2018

Joseph M Connors

3

Joseph M Connors

1 reference

16 May 2018

Nicholas Voss

13

Nicholas J Voss

1 reference

16 May 2018

Cynthia L Toze

2

Cynthia L Toze

1 reference

16 May 2018

Donna Hogge

8

Donna E Hogge

1 reference

16 May 2018

Stephen H Nantel

10

Stephen H Nantel

1 reference

16 May 2018

Julye C Lavoie

9

Julye C Lavoie

1 reference

16 May 2018

author name string

Richard T Doocey

1

1 reference

16 May 2018

Thomas J Nevill

4

1 reference

16 May 2018

Michael J Barnett

6

1 reference

16 May 2018

Donna L Forrest

7

1 reference

16 May 2018

John D Shepherd

11

1 reference

16 May 2018

Heather J Sutherland

12

1 reference

16 May 2018

Clayton A Smith

14

1 reference

16 May 2018

Kevin W Song

15

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 October 2005

1 reference

16 May 2018

British Journal of Haematology

published in

1 reference

16 May 2018

volume

131

1 reference

16 May 2018

issue

2

1 reference

16 May 2018

page(s)

223-230

1 reference

16 May 2018

Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05755.X

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05755.X

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05755.X

Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05755.X

Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05755.X

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05755.X

Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05755.X

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05755.X

Transformed lymphoma: an Achilles' heel of non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05755.X

Graft-vs.-lymphoma effect in various histologies of non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05755.X

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05755.X

MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05755.X

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05755.X

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05755.X

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05755.X

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05755.X

Allogeneic peripheral blood stem cell transplantation for high-risk non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05755.X

10.1111/J.1365-2141.2005.05755.X

21 January 2018

Identifiers

DOI

1 reference

16 May 2018

PubMed ID

16197454

1 reference

16 May 2018